Pioneering for patients

We are Galapagos

We are a fully integrated biotechnology company united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life. We focus on the key therapeutic areas of immunology and oncology, where we have developed a deep scientific expertise in multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to commercialized programs and our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

 

Learn more about Galapagos

IN THE SPOTLIGHT

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Job Openings

Loading...

All Current Openings